Literature DB >> 18536027

Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.

Donatus U Ekwueme1, Ingrid J Hall, Lisa C Richardson, James G Gardner, Janet Royalty, Trevor D Thompson.   

Abstract

BACKGROUND: The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) covers the direct clinical costs of breast and cervical cancer screening and diagnostic follow-up for medically underserved, low-income women. Personal costs are not covered. In this report, the authors estimated personal costs per woman participating in NBCCEDP mammography screening by race/ethnicity and also estimated lifetime personal costs (ages 50-74 years).
METHODS: A decision analysis model was constructed and parameterized by using empiric data from a retrospective cohort survey of mammography rescreening among women ages 50 years to 64 years who participated in the NBCCEDP. Data from 1870 women were collected from 1999 to 2000. The model simulated the flow of resources incurred by a woman participating in the NBCCEDP. The analysis was stratified by annual income into 2 scenarios: Scenario 1, <$10,000; and Scenario 2, from $10,000 to <$20,000. Sensitivity analyses were conducted to appraise uncertainty, and all costs were standardized to 2000 U.S. dollars.
RESULTS: In Scenario 1, for all races/ethnicities, a woman incurred a 1-time cost of $17 and a discounted lifetime cost of $108 for 10 screens and $262 for 25 screens; in Scenario 2, these amounts were $31 and from $197 to $475, respectively. In both scenarios, a non-Hispanic white woman incurred the highest cost. The sensitivity analyses revealed that >70% of cost incurred was attributable to opportunity cost.
CONCLUSIONS: Capturing and quantifying personal costs will help ascertain the total cost (ie, societal cost) of providing mammography screening to a medically underserved, low-income woman participating in a publicly funded cancer screening program and, thus, will help determine the true cost-effectiveness of such programs. (c) 2008 American Cancer Society

Entities:  

Mesh:

Year:  2008        PMID: 18536027     DOI: 10.1002/cncr.23613

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs.

Authors:  Justin G Trogdon; Donatus U Ekwueme; Sujha Subramanian; Jacqueline W Miller; Faye L Wong
Journal:  Cancer Causes Control       Date:  2019-06-11       Impact factor: 2.506

2.  Economics of public health programs for underserved populations: a review of economic analysis of the National Breast and Cervical Cancer Early Detection Program.

Authors:  Jaya S Khushalani; Justin G Trogdon; Donatus U Ekwueme; K Robin Yabroff
Journal:  Cancer Causes Control       Date:  2019-10-09       Impact factor: 2.506

3.  National Breast and Cervical Cancer Early Detection Program data validation project.

Authors:  Christie R Eheman; Steven Leadbetter; Vicki B Benard; A Blythe Ryerson; Janet E Royalty; Donald Blackman; Lori A Pollack; Paula Willey Adams; Fran Babcock
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

4.  Cost of services provided by the National Breast and Cervical Cancer Early Detection Program.

Authors:  Donatus U Ekwueme; Sujha Subramanian; Justin G Trogdon; Jacqueline W Miller; Janet E Royalty; Chunyu Li; Gery P Guy; Wesley Crouse; Hope Thompson; James G Gardner
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

5.  Mammograms on-the-go-predictors of repeat visits to mobile mammography vans in St Louis, Missouri, USA: a case-control study.

Authors:  Bettina F Drake; Salmafatima S Abadin; Sarah Lyons; Su-Hsin Chang; Lauren T Steward; Susan Kraenzle; Melody S Goodman
Journal:  BMJ Open       Date:  2015-03-20       Impact factor: 2.692

6.  Empirical evidence of the continuing improvement in cost efficiency of an endoscopic surveillance programme for gastric cancer in Singapore from 2004 to 2010.

Authors:  Hui Jun Zhou; Shu Chuen Li; Nasheen Naidoo; Feng Zhu; Khay Guan Yeoh
Journal:  BMC Health Serv Res       Date:  2013-04-15       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.